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Abstract
The HIV-1 Trans-Activator of Transcription (Tat) protein binds to multiple host cellular factors and greatly enhances the level
of transcription of the HIV genome. While Tat’s control of viral transcription is well-studied, much less is known about the
interaction of Tat with the human genome. Here, we report the genome-wide binding map of Tat to the human genome in
Jurkat T cells using chromatin immunoprecipitation combined with next-generation sequencing. Surprisingly, we found
that ,53% of the Tat target regions are within DNA repeat elements, greater than half of which are Alu sequences. The
remaining target regions are located in introns and distal intergenic regions; only ,7% of Tat-bound regions are near
transcription start sites (TSS) at gene promoters. Interestingly, Tat binds to promoters of genes that, in Jurkat cells, are
bound by the ETS1 transcription factor, the CBP histone acetyltransferase and/or are enriched for histone H3 lysine 4 tri-
methylation (H3K4me3) and H3K27me3. Tat binding is associated with genes enriched with functions in T cell biology and
immune response. Our data reveal that Tat’s interaction with the host genome is more extensive than previously thought,
with potentially important implications for the viral life cycle.
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Introduction
After gaining entry into host cell, the HIV-1 genome is reverse-
transcribed and the proviral DNA is integrated into the host
genome. Subsequently, the HIV-1 provirus is transcribed allowing
assembly and release of new viral particles from the infected cell.
HIV-1 Tat is essential for efficient viral gene expression and
replication [1]. By recruiting the general RNA polymerase II
elongation factor P-TEFb to Tat response element (TAR) that
forms at the 59 end of nascent viral transcripts, Tat promotes
efficient elongation of viral transcription [2]. Moreover, Tat
acetylation by cellular histone acetyltransferases (HATs) such as
p300, CBP and PCAF is crucial for its transactivation activity [3].
While the role of Tat in viral gene expression has been well
studied, much less is known about the interaction of Tat with the
host genome. Previous studies that aimed to define the role of Tat
at the host gene promoters found that Tat regulates transcription
of the interleukin 6 [4], MHC class I [5], ß2 microglobulin [6] and
mannose receptor [7] promoters. Tat also induces host cell
apoptosis through association with promoters of PTEN and two
PP2A subunits [8]. Therefore, Tat may have roles in regulation of
gene expression from the viral as well as the host genome.
However, a genome-wide map of Tat interaction with the human
genome is still lacking. Such a binding map may reveal additional
roles for Tat in creating the proper cellular environment for
generating progeny virions.
To generate a genome-wide map of Tat binding to the human
genome, we performed chromatin immunoprecipitation combined
with next generation sequencing (ChIP-seq) of Tat in Jurkat T cells
(Jurkat-Tat). We also utilized microarrays to compare global gene
expression changes in Jurkat-Tat versus Jurkat T cells and related
the expression differences to histone acetylation changes. We
found that the bulk of Tat binding sites are outside the immediate
promoter regions of genes. Intriguingly, Tat binds preferentially to
specific DNA repetitive elements, especially the Alu repeat
elements. Binding of Tat to the promoter regions did not correlate
with gene expression. The majority of Tat binding sites at gene
promoters in Jurkat-Tat cells are in close proximity with regions
bound by the ETS1 transcription factor or CBP in Jurkat T cells.
Our data provide the first comprehensive map of Tat binding to
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the human genome, revealing an unexpected array of target
regions.
Results
Genome-wide Tat binding locations defined by ChIP-seq
To determine whether Tat binds to specific regions in the host
genome, we performed ChIP-seq to map Tat binding sites in
Jurkat T cells that stably express Tat under G418 selection [9]. We
first validated Tat expression in Jurkat-Tat cells with Western
blotting (Figure S1). Subsequently, we sequenced both input and
ChIPed Tat-bound DNA using the Illumina GAIIx Sequencer.
The obtained sequences were aligned to the human genome
(version Hg19) using the Bowtie software [10]. For both input and
ChIPed samples, ,62% of all sequences were uniquely aligned to
the human genome (Table 1). We segmented the human genome
into 100 bp windows and calculated the ChIPed DNA read
counts, which were compared to input DNA read counts in each
window. Using the Poisson distribution, we calculated P-values for
the enrichment of ChIPed reads in each window. Significant peaks
were defined as those windows with a P-value,1024 and with two
neighboring windows at the same significance P-value. Based on
these criteria, we identified 2074 genomic regions occupied by Tat
in Jurkat-Tat T cells.
Using the cis-regulatory element annotation system (CEAS)
software [11] to determine the Tat binding distribution pattern
across individual chromosomes, we observed that chromosomes 2,
9, 14, 15, 21 and 22 were significantly (P,1024) enriched for Tat
binding (Figure 1A). The majority (82%) of Tat binding occurs
within introns and intergenic regions in the genome (Figure 1B).
Intergenic regions are defined as those regions that are at least
3 kilo bases (kb) away from any known gene. Only ,7% of Tat
binding sites are located within the promoter regions. These data
suggest that Tat binding to the genome is non-random, with
preferential binding to certain chromosomes and intergenic
regions.
Tat binding loci are enriched within repeat sequences
To determine whether Tat binding regions are associated with
specific genomic features, we obtained the coordinates of various
DNA elements from the UCSC table browser website [12]. To our
surprise, we found that 53% of Tat bound regions lie within
repeat-masker (rmsk) regions, which record repeat elements found
by RepeatMasker [13,14] (Figure 2A). We systematically deter-
mined the enrichment of Tat binding in various repeat elements
and found that, strikingly, 58 percent of all repeat elements bound
Table 1. ChIP-seq alignment results using Bowtie 0.12.7
(Hg19).
DNA Total reads Aligned Reads (%)
Input 42249133 26416727 (62.5)
ChIPed 44360277 27831745 (62.7)
doi:10.1371/journal.pone.0026894.t001
Figure 1. Chromosomal distribution and genomic location of Tat binding sites. (A) Enrichment pattern of Tat-bound regions among
individual chromosomes is shown as a bar chart. Percent of total Tat-binding sites (red bars) and what would be expected by random chance (blue
bars) for each chromosome is shown. The asterisks denotes enrichment P-value,1024. (B) Distribution of all Tat-binding peaks in relation to gene
structure is shown as a pie chart. Intergenic regions are defined as at least 3 kb away from the start and end of any transcript.
doi:10.1371/journal.pone.0026894.g001
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by Tat are Alu repeats (Figure 2B). In fact, the top ten repeat
element types bound by Tat all belong to the Alu family of DNA
repeats (Figure 2C). These data reveal that a large fraction of Tat
binding regions in the genome are within DNA repeat elements,
especially the Alu sequences.
Tat binding is enriched in the middle to the 39 end of Alu
elements
Since more than one third of Tat-bound genomic regions
contain Alu elements, we sought to determine the binding profile
of Tat to Alu elements. As shown in Figure 3A, Alu elements have
an average size of 300 base pairs (bp). We generated an average
profile of Tat binding centered at the start of all Tat-bound Alu
elements. The profile of Tat enrichment over Alu elements was
generated by averaging P-values of Tat binding enrichment in
100-bp windows 61 kb from the start of Alu elements. Tat
binding on average peaked in the middle of Alu elements with a
skewed enrichment toward the 39 end and downstream regions, up
to 200 bp past the average length of an Alu element (Figure 3A).
Figure 3B shows an example of Tat binding at an Alu element in
an intergenic region of chromosome 10 as indicated. We then
asked whether Tat-bound Alu-elements are enriched at specific
genomic regions using the CEAS software [11]. The Tat-bound
Alu elements are primarily located in introns and intergenic
regions of the genome (Figure 3C). In comparison to global Tat
binding patterns, Alu elements bound by Tat are more enriched
within introns (45% vs 53%). Essentially none of the Tat-bound
Alu elements was located within coding exons. Altogether, our
data reveals that Tat binds specifically to a fraction of Alu elements
within the human genome. These Alu elements may be near or
within the introns of genes with functions potentially related to the
viral life cycle such as the Alu element shown in Figure 3B.
Genomic regions bound by Tat are associated with genes
enriched in T cell-related functions
As the majority of genomic regions bound by Tat are at least
3 kb away from any TSS, we asked if the nearest genes to Tat
binding sites are enriched for specific functions. To observe long
range interactions between Tat binding sites and their target
genes, we used the Genomic Regions Enrichment Annotations
Tool (GREAT) [15] to determine whether genomic regions bound
by Tat are located in potential cis-regulatory regions of genes
important for HIV function. GREAT analysis of Tat-bound
regions revealed that the genes potentially associated with distal
Tat binding are mostly 5 kb or further away from Tat binding
sites. This distribution implies that there may be long range
interactions between Tat and its potential target genes (Figure 4A).
In support of this, genes associated with regions bound by Tat are
Figure 2. Tat binds mainly to DNA repeat elements. (A) Distribution of Tat-binding peaks in repeat versus non-repeat elements is shown as a
pie chart. (B) Distribution of Tat-binding peaks within repeat elements in Alu versus non-Alu sequences is shown as a pie chart. (C) Percent of Tat-
binding peaks within individual repeat element subtypes is shown for the top 20 enriched elements.
doi:10.1371/journal.pone.0026894.g002
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significantly enriched in Mouse Genome Informatics (MGI)
Phenotype ontology terms related to T cell function (Figures 4B
and 4C). MGI analyzes the knockout phenotypes of mouse genes
that are homologous to the queried human genes. The mouse
homologues of the potentially Tat-regulated genes exhibit
knockout phenotypes such as changes in T cell morphology and
reduced number of CD4+ and CD8+ T cells (Figure 4B). Similar
gene ontology terms were observed when only genes associated
with Tat-bound Alu elements were used for MGI analysis
(Figure 4C). These data suggest that Tat may exert its effects on
the host genes by binding to distant cis-regulatory elements.
Global gene expression changes in Jurkat-Tat cells
To relate global gene expression changes to Tat binding, we
used Agilent microarrays to compare global gene expression
between Jurkat and Jurkat-Tat cells. Overall, 475 and 319
transcripts showed greater than two-fold increase and decrease
in gene expression, respectively. To investigate the functions of the
Figure 3. Analysis of Tat binding to Alu elements. (A) Average P-value of Tat-binding profile centered at the start of Alu elements for all Tat-
bound Alu elements is shown. The x axis depicts 61 kb away from start of Tat-bound Alu elements in 100-bp intervals. The y axis denotes 2log10 of
Tat-binding enrichment P-value of ChIPed Tat DNA count over input DNA count. (B) Genome browser representation of Tat enrichment profile
compared to the input DNA at a representative Alu element is shown. The peak height corresponds to read counts. (C) Distribution of Tat-bound Alu
elements with respect to gene structure is shown as a pie chart.
doi:10.1371/journal.pone.0026894.g003
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deregulated genes and their relevance to Tat over expression, we
performed Gene Ontology (GO) enrichment analysis using
DAVID [16]. Genes overexpressed in Jurkat-Tat cells are
enriched in cell immune response, cell adhesion, and regulation
of cell death (Figure 5A). However, for the down-regulated genes,
no significant GO enrichment was found. To determine whether
Tat binding is associated with increased or decreased expression of
its target genes, we used the GREAT assigned gene-peak
associations to correlate Tat binding to gene expression.
Surprisingly, we found no significant correlation. Additionally,
we performed ChIP combined with Agilent promoter microarrays
(ChIP-chip) to monitor changes in histone H3 lysine 9 acetylation
(H3K9ac)—a histone modification associated with gene activity—
in Jurkat-Tat versus Jurkat cells. We found that changes in
H3K9ac correlated positively with gene expression changes;
promoter regions of gene that are up- and down-regulated in
Figure 4. Functional annotation of Tat binding regions. (A) The bar chart shows the distribution of the distances between Tat binding peaks
and transcriptional start sites (TSS). Note that a Tat peak may be assigned to more than one gene. Functional annotation of (B) Tat-bound regions and
(C) Tat-bound Alu elements, using gene ontology terms generated by Mouse Genome Informatics (MGI) from mouse homologous gene knock out
phenotypes. The x-axis values are 2log10 of binomial raw P-values.
doi:10.1371/journal.pone.0026894.g004
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Jurkat-Tat cells have higher and lower levels of H3K9ac,
respectively, compared to Jurkat cells (Figure 5B). These data
indicate that changes in gene expression are associated with similar
changes in histone acetylation but Tat may have more subtle
effects on gene expression that is not detected by our microarray
analysis.
Tat in Jurkat-Tat cells binds to locations occupied by CBP
and ETS1
To determine if Tat binding sites are associated with specific
chromatin marks, cellular transcription factors or co-factors, we
searched the Gene Expression Omnibus (GEO)[17] for published
ChIP-seq data in Jurkat or Jurkat-Tat cells. We found five datasets
that examined global distributions of ETS1, CBP, RUNX1, H3K4
tri-methylation (H3K4me3) and H3K27me3 in Jurkat cells
(GSE23080, GSE17954 [18]). No published dataset in Jurkat-
Tat cells was found. ETS1 is a transcription factor that is highly
expressed in lymphoid lineage cells and is important for regulating
functions of immune cells [19]. In mouse models, inactivation of
ETS1 leads to T cell apoptosis [20]. ETS1 and Tat were
previously shown to bind at the same region upstream of IL-10
promoter and induce IL-10 transcription [21]. P300 and CBP
HATs acetylate Tat and serve as co-activators of Tat-dependent
HIV-1 gene expression [3]. RUNX1 is a member of Runt-related
transcription factor (RUNX) family of genes that function in
normal hematopoiesis. H3K4me3 and H3K27me3 are histone
modifications that are generally associated with gene activity and
repression, respectively [22].
We downloaded ChIP-seq raw data from GEO [17] and
compared each ChIP channel to its corresponding input DNA
from the same experimental set. Using the same peak finding
algorithm described above with a P-value cutoff of ,1024, we
defined significant peaks of CBP, ETS1, H3K4me3, H3K27me3
in Jurkat T cells. For RUNX1, we found much less significant
reads using P-value of 1024. To get more similar numbers of total
significant peaks, P-value of 1022 was used to determine significant
reads for RUNX1. Significant peaks found in Jurkat T cells were
then compared to Tat binding sites in Jurkat-Tat cells. We defined
positive co-occupancy of each factor with Tat when there was at
least one significant peak of binding within 6500 bp of the Tat-
binding sites. Figure 6A shows the fraction of all (2074) Tat
binding sites that are occupied by the indicated factors in Jurkat
cells. Only ,12% of all Tat binding sites coincide with H3K4me3
and/or H3K27me3 and even less so with CBP or ETS1. However,
when the analysis is limited to the Tat binding sites within61 kb of
TSS regions (162 sites), 55% and 42% of Tat peaks are bound by
ETS1 and CBP, respectively, in Jurkat cells; 35% are co-occupied
by both factors (Figure 6B). Only 1% of Tat binding sites near TSS
overlap with RUNX1 binding in Jurkat cells with P-value of 1022
and 1024. Furthermore, 28% of Tat TSS binding sites are enriched
for H3K4me3 and H3K27me3 in Jurkat cells, including 58% of
binding sites with both ETS1 and CBP bound near the TSS
(Figure 6B). Figure 6C shows an example of such genes. The
promoter of ZNF143 gene is co-occupied by ETS1 and CBP and
enriched for H3K4me3 and H3K27me3 in Jurkat cells. The same
region is bound by Tat in Jurkat-Tat cells. In contrast, no significant
co-occupancy of Tat in Jurkat-Tat and RUNX1 in Jurkat cells was
found near TSS. Although the occupancy of these factors in Jurkat-
Tat cells is not known, our analysis raises the possibility that specific
cellular transcription factors may help recruit Tat or denote the
genomic regions to which Tat binds.
Discussion
We have generated a global map of Tat binding to the human
genome. Surprisingly, the majority of Tat target regions lie within
DNA repeat elements. In fact, over 30% of all Tat target regions
are located at or near Alu elements. Interestingly, Tat increases the
transcription of Alu repeat elements by increasing the activity of
Figure 5. Gene expression profile of Jurkat-Tat cells. (A) Gene ontology annotation of genes with more than two-fold change in expression
using DAVID. (B) Relationships of gene expression and H3K9ac changes to Tat-binding are shown. Genes are arranged in descending order based on
their expression in Jurkat-Tat versus Jurkat cells. Each row represents one gene. For H3K9ac ChIP-chip analysis, each column represents a 500-bp
window, spanning 25.5 to +2.5 kb of annotated TSS. Moving average of H3K9ac enrichment in three consecutive 500-bp windows is shown in each
column (right panel).
doi:10.1371/journal.pone.0026894.g005
Genome-Wide Map of HIV-1 Tat to the Human Genome
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e26894
cellular transcription factor TFIIIC in Jurkat cells [23]. Since Alu
elements antagonize the interferon-induced protein kinase R
(PKR) activation [24] and PKR is known to repress protein
synthesis when cells are under stress, Tat binding at Alu elements
may be important to enable efficient viral replication in the host
cell. In addition, these Alu elements may affect regulation of genes
with functions related to HIV-1 biology.
In relation to gene regulation, Tat binding sites are distal to
genes with functions in T cell biology as determined by knockout
models in mice. These data suggest that Tat may exert its effects
on its target genes through distant regulatory elements. If so, then
Tat binding, in and of itself, may highlight previously unknown cis-
regulatory elements within the genome. We did not find a
significant correlation between Tat binding and gene expression.
The effects of Tat on gene expression may be too subtle for the
microarrays to detect. Alternatively, Tat may affect the regulation
of its target genes through effects on mRNA structure that is not
evident by expression analysis.
We found only a few genes with Tat binding to the vicinity of
their TSS. This is partly due to the stringent cutoff used in this study
to maintain a False Discovery Rate (FDR) under 5%. For instance,
gene promoters previously shown to be bound by Tat binding such
as IL-6 [4] and ß2 microglobulin [6], showed some Tat binding
above background but did not pass our criteria for statistical
significance. Also, previous studies used different cell culture systems
to determine Tat binding in vivo. These differences may also lead to
identification of different sets of target genes.
Since Tat is not known to bind DNA directly, the mechanism
by which Tat binds to specific regions of the genome may partly
involve interactions with host cellular factors. By comparing our
Tat binding data to the published datasets in Jurkat cells, we found
that Tat binds to gene promoters that were bound by ETS1 and
CBP, but not with RUNX1, in non-Tat expressing Jurkat cells. A
similar positive relationship was found between Tat binding and
two histone methylation marks, H3K4me3 and H3K27me3.
These data raise the possibility that Tat may distinguish its target
regions through specific host transcription co-factors or chromatin
marks. However, our data does not include or exclude ETS1, CBP
or the histone modifications as the mediators of Tat recruitment.
Binding analyses of specific Tat mutants that disrupt its interaction
with specific cellular factors are required to determine potential
mechanisms of Tat recruitment. It is also possible that Tat binds to
the genome through an RNA component. Nonetheless, our results
demonstrate that in addition to known roles for Tat in enhancing
Figure 6. Tat binding peaks in Jurkat-Tat cells are associated with specific cellular factors and chromatin marks in Jurkat cells. (A)
Percent of all Tat peaks in Jurkat-Tat cells that are bound by CBP, ETS1, RUNX1, H3K4me3 and/or H3K27me3 in Jurkat cells is shown. (B) Percent of Tat
peaks at TSS in Jurkat-Tat cells that are bound by CBP, ETS1, RUNX1, H3K4me3 and H3K27me3 in Jurkat cells is shown. (C) Shown is the Tat
enrichment profile at the ZNF143 gene promoter in Jurkat-Tat cells compared to CBP, ETS1, RUNX1, H3K4me3, H3K27me3 enrichment at the same
genomic location in Jurkat cells. The peak heights (y-axis) correspond to read counts. The x-axis represents the genomic coordinates.
doi:10.1371/journal.pone.0026894.g006
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elongation of viral transcription, Tat also binds to the host genome
at specific genomic locations with potentially important conse-
quences for the viral life cycle.
Materials and Methods
Cell culture
Jurkat T cells were obtained from ATCC (TIB-15) and cultured
under standard tissue culture conditions. Jurkat-Tat cells were
obtained from the NIH AIDS Research & Reference Reagent
Program and maintained in RPMI supplemented with 10% fetal
bovine serum, 1% penicillin and streptomycin and 800 mg/ml of
G418.
Western blotting
Cells were lysed with RIPA buffer (50 mM Tris-HCl pH 8.0,
150 mM NaCl, 1% NP-40, 0.1% SDS, 1% sodium deoxycholate)
supplemented with protease inhibitors (Roche). Cell lysates were
subjected to SDS-PAGE and analyzed by Western blot using
standard procedures. The antibodies used for Western blotting
were as follows: Anti-Tat (Abcam ab43014), Anti-Beta-actin
(Abcam ab8224), Anti-H3 (Abcam ab10799).
Chromatin immunoprecipitation and ChIP-seq library
preparation
Jurkat-Tat cells in exponential growth phase were fixed with 1%
formaldehyde (v/v) for 10 min at 37uC. Fixation was stopped by
addition of glycine to a final concentration of 140 mM. Cell were
lysed and chromatin was digested with the micrococcal nuclease
from S. aureus (Roche) for 90 min at 4uC according to the
manufacturer’s instructions, re-suspended in lysis buffer and
sonicated with Misonix ultrasonic liquid processor. 1% of the
lysate was used as an input control. Lysates were immunoprecip-
itated with 5 mg of anti-Tat antibodies (Abcam ab43014) using the
standard ChIP protocol. Both purified input and Tat chromatin
samples were used to prepare ChIP-seq libraries according to the
manufacturer’s instructions (Illumina). Libraries were sequenced
using Illumina Genome Analyser II to obtain 76 bp-long reads.
Chromatin immunoprecipitation and microarray
hybridization
Jurkat-Tat and Jurkat cells in exponential growth phase were
fixed with 1% formaldehyde (v/v) for 10 min at 37uC. Fixation
was stopped by addition of glycine to a final concentration of
140 mM. Histone H3 acetyl lysine 9 antibody (Upstate 07-352)
was used for ChIP. The ChIP-chip and subsequent analysis were
performed essentially as described previously [25].
ChIP-seq data analysis
Sequenced reads were base-called using the standard Illumina
software. Bowtie 0.12.7 was used to align the reads to the Human
genome (Hg19) allowing up to two mismatches; reads that aligned
to more than one location in the genome were discarded. For
unaligned reads, 5 bp from the 59 end and 25 bp from the 39 end
of the reads were trimmed and re-aligned to the genome. The total
number of reads in the input sample was normalized to the ChIP
counts. Genomic regions with significant enrichment of Tat
chromatin over input chromatin were calculated within 100 bp
windows that tiled the genome. The P-value for enrichment of
ChIP versus input reads was calculated using the cumulative
Poisson distribution.
Expression profiling
Total RNA was isolated from Jurkat and Jurkat-Tat cells using
the RNeasy Mini kit (Qiagen). cRNAs were generated from
250 ng of total RNA and labeled with Cy3 (Jurkat) or Cy5 (Jurkat-
Tat) using the Low Input Quick Amp Labeling Kit (Agilent)
according to manufacturer’s instructions. Labeled cRNAs were
hybridized to the Agilent Human whole-genome array (G2534-
600110) according to Agilent protocol. Raw intensity data from
resulting gene expression data were normalized by medium
background-subtracted intensities between Cy5 and Cy3 channels
followed by LOWESS normalization using Matlab. Normalized
log2 ratios of Jurkat-Tat cRNAs (Cy5) over Jurkat cRNAs (Cy3)
were calculated and results from replicates were averaged. Gene
ontology enrichment analysis was performed using The Database
for Annotation, Visualization and Integrated Discovery (DAVID)
v6.7 [16].
All data have been deposited in the Gene Expression Omnibus
(GEO) [17] under accession number GSE30739.
Supporting Information
Figure S1 Tat is expressed in Jurkat-Tat cells. Western
blots of the indicated factors in normal Jurkat T cells (Jurkat) and
Jurkat cells stably expressing Tat (Jurkat-Tat).
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